Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment

被引：28
|
作者：
Guo, Yelei [1 ]
Feng, Kaichao [2 ]
Tong, Chuan [1 ]
Jia, Hejin [2 ]
Liu, Yang [3 ]
Wang, Yao [1 ]
Ti, Dongdong [1 ]
Yang, Qingming [2 ]
Wu, Zhiqiang [1 ]
Han, Weidong [1 ,2 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Mol Biol & Immunol, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Biotherapeut, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Hematol, Beijing, Peoples R China
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2020年 / 17卷 / 04期
基金：
中国国家自然科学基金;
关键词：
RECEPTOR; CD38;
D O I：
10.1038/s41423-019-0355-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：430 / 432
页数：3
相关论文
共 50 条
  • [1] Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment
    Yelei Guo
    Kaichao Feng
    Chuan Tong
    Hejin Jia
    Yang Liu
    Yao Wang
    Dongdong Ti
    Qingming Yang
    Zhiqiang Wu
    Weidong Han
    Cellular & Molecular Immunology, 2020, 17 : 430 - 432
  • [2] DUAL CD19/CD22 CAR T CELLS SHOW FEASIBILITY IN PEDIATRIC/YOUNG ADULT B-ALL
    不详
    CANCER DISCOVERY, 2021, 11 (12) : 2958 - 2958
  • [3] Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
    Wenjie Li
    Lixia Ding
    Wenhua Shi
    Xinyu Wan
    Xiaomin Yang
    Jing Yang
    Tianyi Wang
    Lili Song
    Xiang Wang
    Yani Ma
    Chengjuan Luo
    Jingyan Tang
    Longjun Gu
    Jing Chen
    Jun Lu
    Yanjing Tang
    Benshang Li
    Journal of Translational Medicine, 21
  • [4] Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
    Li, Wenjie
    Ding, Lixia
    Shi, Wenhua
    Wan, Xinyu
    Yang, Xiaomin
    Yang, Jing
    Wang, Tianyi
    Song, Lili
    Wang, Xiang
    Ma, Yani
    Luo, Chengjuan
    Tang, Jingyan
    Gu, Longjun
    Chen, Jing
    Lu, Jun
    Tang, Yanjing
    Li, Benshang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [5] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [6] Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL
    Shalabi, Haneen
    Yates, Bonnie
    Shahani, Shilpa
    Qin, Haiying
    HIghfill, Steven L.
    Panch, Sandhya
    Tran, Minh
    Stroncek, David
    Hoffman, Leah
    Little, Lauren
    Graap, Katherine
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Wang, Hao-Wei
    Fry, Terry J.
    Shah, Nirali N.
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies
    Hossain, Nasheed
    Sahaf, Bita
    Abramian, Matthew
    Spiegel, Jay Y.
    Kong, Katie
    Kim, Stephen
    Mavroukakis, Sharon
    Oak, Jean
    Natkunam, Yasodha
    Meyer, Everett H.
    Frank, Matthew J.
    Feldman, Steven A.
    Long, Steven R.
    Qin, Haiying
    Fry, Terry J.
    Muffly, Lori S.
    Mackall, Crystal L.
    Miklos, David B.
    BLOOD, 2018, 132
  • [8] CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
    Molostova, Olga
    Shelikhova, Larisa
    Muzalevsky, Yakov
    Kazachenok, Alexey
    Khismatullina, Rimma
    Abugova, Julia
    Kurnikova, Elena
    Trakhtman, Pavel
    Pershin, Dmitry
    Zubachenko, Viktoria
    Fadeeva, Maria
    Popov, Alexander M.
    Illarionova, Olga
    Miakova, Natalia
    Litvinov, Dmitry
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2021, 138
  • [9] Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL
    Aparicio-Perez, Clara
    Carmona, MDolores
    Benabdellah, Karim
    Herrera, Concha
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
    Jia, Hejin
    Wang, Zhenguang
    Wang, Yao
    Liu, Yang
    Dai, Hanren
    Tong, Chuan
    Guo, Yelei
    Guo, Bo
    Ti, Dongdong
    Han, Xiao
    Yang, Qingming
    Wu, Zhiqiang
    Han, Weidong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
12345